Kenneth Krogulski - 24 Mar 2023 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
24 Mar 2023
Net transactions value
+$9,850
Form type
4
Filing time
27 Mar 2023, 17:31:51 UTC
Previous filing
23 Dec 2022
Next filing
08 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Award $9,850 +5,000 +2.4% $1.97 209,955 24 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock award will vest 100% on March 24, 2024.